Atlas Trials

A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis

Clinical trial NCT02727764 · UNKNOWN

Trial details

NCT number
NCT02727764
Sponsor
Arthrogen
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Arthritis, RheumatoidOsteo Arthritis
Start date
2017-04-20
Primary completion
2022-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.